Trial intelligence / Profile preview

HAIC with FOLFOX in advanced hepatocellular carcinoma

NCT02987699Phase 2Unknown

Sponsor
Sun Yat-sen University
Start
Nov 2016
Primary completion
Apr 2017
Modality
DNA Intercalators/Alkylators, Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of oxaliplatin, fluorouracil, folinic acid in hepatocellular carcinoma (HCC), sponsored by Sun Yat-sen University. Status: unknown.

02

Drugs

oxaliplatinfluorouracilfolinic acid
03

Conditions

hepatocellular carcinoma (HCC)

Beyond the preview

Go deeper on NCT02987699.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02987699.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call